Kris Ann P. Schultz

5.7k total citations · 1 hit paper
94 papers, 2.9k citations indexed

About

Kris Ann P. Schultz is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, Kris Ann P. Schultz has authored 94 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Surgery, 52 papers in Pulmonary and Respiratory Medicine and 11 papers in Reproductive Medicine. Recurrent topics in Kris Ann P. Schultz's work include Congenital Diaphragmatic Hernia Studies (68 papers), Tracheal and airway disorders (22 papers) and Neonatal Respiratory Health Research (21 papers). Kris Ann P. Schultz is often cited by papers focused on Congenital Diaphragmatic Hernia Studies (68 papers), Tracheal and airway disorders (22 papers) and Neonatal Respiratory Health Research (21 papers). Kris Ann P. Schultz collaborates with scholars based in United States, Canada and Germany. Kris Ann P. Schultz's co-authors include D. Ashley Hill, Louis P. Dehner, Yoav H. Messinger, Gretchen M. Williams, Douglas R. Stewart, Anne K. Harris, Leslie Doros, Jiandong Yang, Amanda Field and Laura A. Harney and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Kris Ann P. Schultz

90 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies

2018 216 citations Kris Ann P. Schultz, Gretchen M. Williams et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kris Ann P. Schultz United States	29	1.6k	1.1k	635	468	369	94	2.9k
Philippe Moerman Belgium	25	819 0.5×	458 0.4×	508 0.8×	483 1.0×	416 1.1×	106	2.6k
Nicola Nicolai Italy	29	2.4k 1.5×	771 0.7×	526 0.8×	111 0.2×	428 1.2×	159	2.8k
Annie Rey France	40	1.5k 0.9×	2.4k 2.1×	590 0.9×	222 0.5×	1.1k 2.9×	78	4.7k
Gabriella Cohn‐Cedermark Sweden	22	2.0k 1.3×	694 0.6×	771 1.2×	81 0.2×	670 1.8×	61	2.7k
Klaus‐Peter Dieckmann Germany	36	3.4k 2.1×	950 0.8×	1.5k 2.3×	131 0.3×	1.4k 3.7×	169	4.1k
Anne K. Harris United States	16	842 0.5×	565 0.5×	200 0.3×	120 0.3×	159 0.4×	45	1.3k
Mary M. Davis United States	26	1.1k 0.7×	515 0.5×	301 0.5×	132 0.3×	197 0.5×	63	1.9k
A. Gerl Germany	32	2.2k 1.4×	745 0.7×	457 0.7×	84 0.2×	544 1.5×	74	2.7k
Stephen A. Kramer United States	30	1.2k 0.7×	666 0.6×	532 0.8×	678 1.4×	154 0.4×	103	2.6k
S.D. Fosså Norway	27	1.1k 0.7×	607 0.5×	397 0.6×	169 0.4×	359 1.0×	71	1.9k

Countries citing papers authored by Kris Ann P. Schultz

Since Specialization

Citations

This map shows the geographic impact of Kris Ann P. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kris Ann P. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kris Ann P. Schultz more than expected).

Fields of papers citing papers by Kris Ann P. Schultz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kris Ann P. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kris Ann P. Schultz. The network helps show where Kris Ann P. Schultz may publish in the future.

Co-authorship network of co-authors of Kris Ann P. Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Kris Ann P. Schultz. A scholar is included among the top collaborators of Kris Ann P. Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kris Ann P. Schultz. Kris Ann P. Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watson, David, Kenneth Chen, Jennifer N. Stall, et al.. (2025). Prognostic Significance of Germline DICER1 Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell Tumor. JCO Precision Oncology. 9(9). e2400902–e2400902. 1 indexed citations

Dholaria, Hetal, Stephen T. Simpson, Carlos Rodríguez‐Galindo, et al.. (2025). One-Two Punch: Combining Chemotherapy and Immunotherapy to Decrease Radiation Dose and Related Toxicity in Children and Adolescents with Nasopharyngeal Carcinoma. Clinical Cancer Research. 31(15). 3124–3132.

Billmire, Deborah F., et al.. (2025). Surgical staging for ovarian sex cord-stromal tumors: What procedural steps are needed?. European Journal of Obstetrics & Gynecology and Reproductive Biology. 312. 114522–114522.

Shulman, David S., Kelly Klega, Nan Chen, et al.. (2024). Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study.. Journal of Clinical Oncology. 42(16_suppl). 11510–11510. 1 indexed citations

Kim, Jung, Jeremy S. Haley, Uyenlinh L. Mirshahi, et al.. (2024). A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance and cancer, thyroid, and other phenotypes in 2 population-scale cohorts. SHILAP Revista de lepidopterología. 2. 101846–101846. 2 indexed citations

Schoettler, Peter, Caroline Smith, Miki Nishitani, et al.. (2024). Anaplastic sarcoma of the kidney ( DICER1 ‐sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/ DICER1 Registry. Pediatric Blood & Cancer. 71(8). e31090–e31090. 3 indexed citations

MacFarland, Suzanne P., Kami Wolfe Schneider, Roland P. Kuiper, et al.. (2024). Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group. Clinical Cancer Research. 30(20). 4566–4571. 6 indexed citations

Michaeli, Orli, Marjolijn C.J. Jongmans, Jonathan D. Wasserman, et al.. (2024). Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes. Clinical Cancer Research. 31(3). 457–465. 4 indexed citations

Kim, Jung, David S. Dickens, Peter A. Argenta, et al.. (2023). Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor. JCO Precision Oncology. 7(7). e2300189–e2300189. 3 indexed citations

10.

Schultz, Kris Ann P., Murali Chintagumpala, Jin Piao, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Rare tumors. Pediatric Blood & Cancer. 70(S6). e30574–e30574. 3 indexed citations

11.

Schneider, Dominik T., Andrea Ferrari, Daniel Orbach, et al.. (2023). A virtual consultation system for very rare tumors in children and adolescents – an initiative of the European Cooperative Study Group in Rare Tumors in Children (EXPeRT). SHILAP Revista de lepidopterología. 3. 100137–100137. 4 indexed citations

12.

Elbracht, Miriam, Julia Carlens, Felix Zeppernick, et al.. (2021). Unusual phenotypes in patients with a pathogenic germline variant in DICER1. Familial Cancer. 22(4). 475–480. 6 indexed citations

13.

Schneider, Dominik T., Daniel Orbach, Tal Ben Ami, et al.. (2021). Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents. Pediatric Blood & Cancer. 68(S4). e29017–e29017. 11 indexed citations

14.

Stewart, Douglas R., Ana F. Best, Gretchen M. Williams, et al.. (2019). Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1. Journal of Clinical Oncology. 37(8). 668–676. 93 indexed citations

15.

Schultz, Kris Ann P., Gretchen M. Williams, Junne Kamihara, et al.. (2018). DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clinical Cancer Research. 24(10). 2251–2261. 216 indexed citations breakdown →

16.

Bauer, Andrew J., Leslie Doros, Kris Ann P. Schultz, et al.. (2016). Macrocephaly associated with the DICER1 syndrome. Genetics in Medicine. 19(2). 244–248. 43 indexed citations

17.

Williams, Gretchen M., Yoav H. Messinger, Douglas R. Stewart, et al.. (2016). Type I and type IR PPB: An update from the International PPB Registry.. Journal of Clinical Oncology. 34(15_suppl). 10517–10517. 1 indexed citations

18.

Doros, Leslie, Kris Ann P. Schultz, Douglas R. Stewart, et al.. (2014). DICER1-Related Disorders. 15(10). 2445–2452. 41 indexed citations

19.

Schultz, Kris Ann P., M. Cristina Pacheco, Jiandong Yang, et al.. (2011). Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: A report from the International Pleuropulmonary Blastoma Registry. Gynecologic Oncology. 122(2). 246–250. 119 indexed citations

20.

Schultz, Kris Ann P., Lu Chen, Zhengjia Chen, et al.. (2010). Health and risk behaviors in survivors of childhood acute myeloid leukemia: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 55(1). 157–164. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact